Cargando…
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials
The herbal medicine rikkunshito has the potential to improve chemotherapy-induced nausea and vomiting (CINV) by stimulating ghrelin secretion. We aimed to evaluate the efficacy and safety of rikkunshito in preventing CINV for patients with lung cancer. Two separate prospective, randomized, phase II...
Autores principales: | Harada, Toshiyuki, Amano, Toraji, Ikari, Tomoo, Takamura, Kei, Ogi, Takahiro, Fujikane, Toshiaki, Fujita, Yuka, Taima, Kageaki, Tanaka, Hisashi, Sasaki, Takaaki, Okumura, Shunsuke, Sugawara, Shunichi, Yokouchi, Hiroshi, Yamada, Noriyuki, Morikawa, Naoto, Dosaka-Akita, Hirotoshi, Isobe, Hiroshi, Nishimura, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776023/ https://www.ncbi.nlm.nih.gov/pubmed/29387008 http://dx.doi.org/10.3389/fphar.2017.00972 |
Ejemplares similares
-
Traditional herbal medicine, Rikkunshito, for chemotherapy-induced nausea and vomiting
por: Morishige, Ken-ichirou
Publicado: (2017) -
Prognostic significance of OX40(+) lymphocytes in tumor stroma of surgically resected small-cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2021) -
Usefulness of criteria for intraoperative Management of Postoperative Nausea and Vomiting
por: Nagase, Satoshi, et al.
Publicado: (2022) -
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007) -
A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy
por: Takeuchi, Satoshi, et al.
Publicado: (2011)